Treatment of Amenorrhea
The best treatment for amenorrhea depends on identifying and addressing the underlying cause, with hormone replacement therapy (transdermal estradiol with cyclic oral progestin) being the preferred first-line treatment for functional hypothalamic amenorrhea to protect bone health. 1
Diagnostic Approach to Guide Treatment
Rule out pregnancy first in all women of reproductive age
Categorize the amenorrhea:
- Primary amenorrhea: absence of menarche by age 16
- Secondary amenorrhea: cessation of menses for ≥3 months in previously regular cycles or ≥6 months in previously irregular cycles
Initial laboratory workup:
- Pregnancy test
- Luteinizing hormone (LH)
- Follicle-stimulating hormone (FSH)
- Prolactin
- Thyroid-stimulating hormone (TSH)
Treatment Based on Specific Causes
1. Functional Hypothalamic Amenorrhea (FHA)
- First-line treatment: Transdermal estradiol (100 μg patch applied twice weekly) with cyclic oral progestin (200 mg for 12 days each month) 1
- Avoid oral contraceptives as they inhibit IGF-1 production via first-pass hepatic metabolism, potentially decreasing osteoblastic activity 1
- Address underlying causes:
- Optimize energy availability through nutritional counseling
- Reduce excessive exercise if present
- Manage psychological stressors
2. Polycystic Ovary Syndrome (PCOS)
- For menstrual regulation: Cyclic progestogen or sequential estrogen plus progestogen 2
- For contraception and hyperandrogenism: Combined oral contraceptives, especially for patients with acne and hirsutism 2
- For fertility: Clomiphene citrate (starting on day 5 of cycle) 3
- Metabolic management: Screen for glucose intolerance and dyslipidemia 4
3. Hyperprolactinemia
- First-line treatment: Dopamine agonists (e.g., bromocriptine) to normalize prolactin levels 2, 5
- For menstrual regulation: Cyclical progestogen or hormone replacement therapy 2
- For contraception: Combined oral contraceptives 2
4. Primary Ovarian Insufficiency
- First-line treatment: Hormone replacement therapy to prevent hypoestrogenic complications (cardiovascular disease and osteoporosis) 2
- Important note: These patients can maintain unpredictable ovarian function and should not be presumed infertile 6, 4
5. Post-Oral Contraceptive Amenorrhea
- For those with normal prolactin: Consider clomiphene citrate challenge test 5
- For those with elevated prolactin and galactorrhea: Bromocriptine therapy (5 mg daily) 5
Special Considerations
Bone Health
- Amenorrhea, particularly FHA, increases risk of osteoporosis and fractures
- Monitor bone mineral density in patients with prolonged amenorrhea
- Calcium and vitamin D supplementation is recommended 1
- Avoid exercise-related LEA (Low Energy Availability) which can impair bone health when energy availability drops below 30 kcal/kg FFM/day in women 1
Contraception
- Despite amenorrhea, contraception may still be needed as ovulation can occur unpredictably
- Important: Contraception is mandatory before starting any potentially teratogenic treatments 1
Common Pitfalls to Avoid
Treating with combined oral contraceptives for FHA: This masks the return of spontaneous menstruation and may not protect bone health 1
Assuming infertility in all cases: Particularly in primary ovarian insufficiency, unpredictable ovarian function may occur 6, 4
Focusing only on menstrual regulation: Treatment should address underlying causes and prevent long-term complications like osteoporosis and cardiovascular disease 2
Overlooking eating disorders: In FHA, disordered eating should be evaluated and addressed 1, 4
Missing pregnancy as a cause: Always rule out pregnancy before initiating any treatment 6, 4
By identifying the specific cause of amenorrhea and implementing appropriate treatment, clinicians can effectively manage this condition while preventing associated complications and preserving fertility when possible.